Time-restricted Eating (TRE) and Protein in Older Adults
The Effects of Time-restricted Eating (TRE) With and Without Additional Protein on Body Composition, Muscle Function and Markers of Metabolic Health in Older Adults
1 other identifier
interventional
80
1 country
1
Brief Summary
The aim this study is to investigate the effects of time-restricted eating (TRE) on body composition, muscle function and markers of metabolic health of adults over 60 years old. This study will compare different variations of TRE - with and without an additional protein. This study involves attending two study days at the University of Surrey for baseline and end-of-intervention measurement of body composition using a gold-standard dual energy x-ray absorptiometry (DEXA) scan; muscle function using hand grip strength and 30-second sit-to-stand tests; weight. A blood sample will be taken at each study visit to measure markers of lipid and glucose control, and insulin sensitivity. Participants will be randomly allocated to one of four study groups:
- control group: maintain habitual dietary patterns
- TRE group: fast for 16 hours overnight, eat between 12-8pm
- TRE + Protein (AM): fast for 16 hours overnight, eat between 12-8pm; take a 30g plant-based protein supplement in the morning
- TRE + Protein (PM): fast for 16 hours overnight, eat between 12-8pm; take a 30g plant-based protein supplement in the afternoon Participants will be asked to follow the intervention according to their allocated group for 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedFirst Posted
Study publicly available on registry
January 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
January 2, 2026
November 1, 2025
1.5 years
November 26, 2025
December 17, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Change from baseline in body composition at 2 months using whole-body dual-energy x-ray absorptiometry (DEXA)
Measured using whole-body dual-energy x-ray absorptiometry (DEXA) In addition to the above, body composition will also be assessed using Tanita Bioelectrical impedance analysis (BIA). Fat free and fat mass will be reported in kg.
For 8 weeks of the assigned study intervention
Change from baseline in muscle function at 2 months
Measured using grip strength
At the start and end of 8 weeks of the assigned study intervention
Change from baseline in muscle function at 2 months
Measured using 30-second sit-to-stand test.
At the start and end of 8 weeks of the assigned study intervention
Secondary Outcomes (5)
Change in fasting glucose control indicators
At the start and end of 8 weeks of the assigned study intervention
Change from baseline in insulin sensitivity at 2 months
At the start and end of 8 weeks of the assigned study intervention
Change from baseline in lipid metabolism at 2 months
At the start and end of 8 weeks of the assigned study intervention
Change from baseline in diet composition at 2 months
At the start, mid-point (week 4) and end of 8 weeks of the assigned study intervention
Feasibility of the assigned TRE intervention
at the end of the 8 week intervention
Study Arms (4)
TRE
EXPERIMENTALParticipants undertaking the TRE intervention
ProtAM TRE
EXPERIMENTALParticipants undertaking the ProtAM TRE intervention
ProtPM TRE
EXPERIMENTALParticipants undertaking the ProtPM TRE intervention
Control
NO INTERVENTIONInterventions
* Participants will be asked to follow a 16:8 TRE protocol, consuming all their daily within 8 hours, between 12 and 8pm, and fast for 16 hours overnight. * Outside of the eating window, participants will be allowed to consume energy-free drinks only, i.e. water, black tea/coffee, 0-calorie soft drinks. * In addition, they will be asked to consume a protein drink containing 30g protein in the afternoon, either 2 hours after their first meal or 2 hours before their last meal of the day.
* Participants will be asked to follow a 16:8 TRE protocol, consuming all their daily within 8 hours, between 12 and 8pm, and fast for 16 hours overnight. * Outside of the eating window, participants will be allowed to consume energy-free drinks only, i.e. water, black tea/coffee, 0-calorie soft drinks.
* Participants will be asked to follow a 16:8 TRE protocol, consuming all their daily within 8 hours, between 12 and 8pm, and fast for 16 hours overnight. * Outside of the eating window, participants will be allowed to consume energy-free drinks only, i.e. water, black tea/coffee, 0-calorie soft drinks. * In addition, they will be asked to consume a protein drink containing 30g protein in the morning, 2 hours before the 8-hour eating window opens at 12pm (i.e. at 10am).
Eligibility Criteria
You may qualify if:
- Gender: male and female
- Age range: 60 years or older
- Fasting for 12 or less hours on a daily basis
- BMI range: 23-30 kg/m2
- Weight stability: no more than 3kg weight gain or loss in the past 3 months
- Regular eating pattern, i.e. 3 meals a day
- Able to prepare the protein supplement
You may not qualify if:
- known renal impairment
- heart attack or stroke in the past three months
- continuous use of supplemental oxygen to manage a chronic pulmonary condition or heart failure
- rheumatoid arthritis
- Parkinson's disease
- active treatment for cancer in the past year
- insulin dependent diabetes mellitus
- taking medications that preclude fasting for 16 h
- actively trying or planning to lose weight
- history of an eating disorder
- outside of stated age or BMI range
- fasting for longer than 12 hours on a daily basis
- unable to prepare the protein supplement
- extreme morning/evening chronotype
- sleep disorders
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Surrey
Guildford, GU2 7XH, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2025
First Posted
January 2, 2026
Study Start
December 1, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
January 2, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Not required or applicable for this study protocol